PI 3-kinase, mTOR, protein synthesis and cancer
- 1 November 2001
- journal article
- research article
- Published by Elsevier BV in Trends in Molecular Medicine
- Vol. 7 (11), 482-484
- https://doi.org/10.1016/s1471-4914(01)02161-x
Abstract
The mTOR kinase is an essential mediator of growth signals that originate from PI3-kinase. Downstream targets of mTOR, p70 S6 kinase and 4E binding protein are important regulators of protein synthesis. Inhibition of mTOR by rapamycin interferes with oncogenic transformation and with tumor development by gain-of-function in PI 3-kinase signaling.Keywords
This publication has 19 references indexed in Scilit:
- Oncogenic kinase signallingNature, 2001
- TOR, a Central Controller of Cell GrowthCell, 2000
- Up-regulation of Akt3 in Estrogen Receptor-deficient Breast Cancers and Androgen-independent Prostate Cancer LinesJournal of Biological Chemistry, 1999
- eIF4 Initiation Factors: Effectors of mRNA Recruitment to Ribosomes and Regulators of TranslationAnnual Review of Biochemistry, 1999
- New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathwayProceedings of the National Academy of Sciences of the United States of America, 1999
- PIK3CA is implicated as an oncogene in ovarian cancerNature Genetics, 1999
- Amplification and overexpression of theAKT2 oncogene in a subset of human pancreatic ductal adenocarcinomasMolecular Carcinogenesis, 1998
- Rapamycin suppresses 5'TOP mRNA translation through inhibition of p70s6kThe EMBO Journal, 1997
- Isolation of DNA Sequences Amplified at Chromosome 19q13.1–q13.2 Including theAKT2Locus in Human Pancreatic CancerBiochemical and Biophysical Research Communications, 1996
- AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas.Proceedings of the National Academy of Sciences of the United States of America, 1992